Long-term exposure to combination antiretroviral therapy and risk of death from specific causes
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Long-term exposure to combination antiretroviral therapy and risk of death from specific causes
Authors
Keywords
-
Journal
AIDS
Volume 26, Issue 3, Pages 315-323
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2011-12-08
DOI
10.1097/qad.0b013e32834e8805
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Fatal and nonfatal AIDS and non-AIDS events in HIV-1-positive individuals with high CD4 cell counts according to viral load strata
- (2011) Joanne Reekie et al. AIDS
- The Coding Causes of Death in HIV (CoDe) Project
- (2011) Justyna D. Kowalska et al. EPIDEMIOLOGY
- A Standardized Algorithm for Determining the Underlying Cause of Death in HIV Infection as AIDS or non-AIDS Related: Results from the EuroSIDA Study
- (2011) Justyna D. Kowalska et al. HIV CLINICAL TRIALS
- Rates of cardiovascular disease following smoking cessation in patients with HIV infection: results from the D:A:D study*
- (2011) K Petoumenos et al. HIV MEDICINE
- Risk of all-cause mortality associated with nonfatal AIDS and serious non-AIDS events among adults infected with HIV
- (2010) Jacqueline Neuhaus et al. AIDS
- Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients
- (2010) Amanda Mocroft et al. AIDS
- Causes of Death in HIV‐1–Infected Patients Treated with Antiretroviral Therapy, 1996–2006: Collaborative Analysis of 13 HIV Cohort Studies
- (2010) CLINICAL INFECTIOUS DISEASES
- Serious Fatal and Nonfatal Non-AIDS-Defining Illnesses in Europe
- (2010) Amanda Mocroft et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Antiretrovirals Induce Endothelial Dysfunction via an Oxidant-Dependent Pathway and Promote Neointimal Hyperplasia
- (2010) Bo Jiang et al. TOXICOLOGICAL SCIENCES
- Association of antiretroviral therapy with fibrinogen levels in HIV-infection
- (2009) Erin Madden et al. AIDS
- Nevirapine Increases High-Density Lipoprotein Cholesterol Concentration by Stimulation of Apolipoprotein A-I Production
- (2009) Remco Franssen et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Reduction in circulating markers of endothelial dysfunction in HIV-infected patients during antiretroviral therapy
- (2009) US Kristoffersen et al. HIV MEDICINE
- Implementing the number needed to harm in clinical practice: risk of myocardial infarction in HIV-1-infected patients treated with abacavir
- (2009) JD Kowalska et al. HIV MEDICINE
- Changes in Causes of Death Among Adults Infected by HIV Between 2000 and 2005: The “Mortalité 2000 and 2005” Surveys (ANRS EN19 and Mortavic)
- (2009) Charlotte Lewden et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Risk of Myocardial Infarction in Patients with HIV Infection Exposed to Specific Individual Antiretroviral Drugs from the 3 Major Drug Classes: The Data Collection on Adverse Events of Anti‐HIV Drugs (D:A:D) Study
- (2009) Signe Westring Worm et al. JOURNAL OF INFECTIOUS DISEASES
- Mortality of Patients Lost to Follow-Up in Antiretroviral Treatment Programmes in Resource-Limited Settings: Systematic Review and Meta-Analysis
- (2009) Martin W. G. Brinkhof et al. PLoS One
- The role of HIV in serious diseases other than AIDS
- (2008) Andrew N Phillips et al. AIDS
- Increased carotid intima-media thickness in HIV patients treated with protease inhibitors as compared to non-nucleoside reverse transcriptase inhibitors
- (2008) Raaj R. Sankatsing et al. ATHEROSCLEROSIS
- Loss to follow-up in an international, multicentre observational study
- (2008) A Mocroft et al. HIV MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More